Boku Narikazu - My portal

Profile Information

Affiliation: -

Degree: 医学(筑波大学)

Researcher number: 50505948
J-GLOBAL ID: 201801020468534176

Papers

Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.

Takashima A, Shitara K, Fujitani K, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Fujii H, Muro K, Esaki T, Choda Y, Takano T, Chin K, Sato A, Goto M, Fukushima N, Hara T, Machida N, Ohta M, Boku N, Shimura M, Morita S, Koizumi W

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 22(1) 155 - 163 1 2019 Peer-reviewed
Imaging peritoneal metastasis of gastric cancer with 18F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept study.

Yoshitaka Honma, Takashi Terauchi, Ukihide Tateishi, Daisuke Kano, Kengo Nagashima, Hirokazu Shoji, Satoru Iwasa, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Narikazu Boku, Yasuhiro Shimada, Yasuhide Yamada

The British journal of radiology 91(1089) 20180259 - 20180259 9 2018 Peer-reviewed
Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis. Cancer Chemother Pharmacol.

Iizumi S, Takashima A, Sakamaki K, Morita S, Boku N

Cancer Chemother Pharmacol. 1 2018 Peer-reviewed
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial

Yung-Jue Bang, Rui-Hua Xu, Keisho Chin, Keun-Wook Lee, Se Hoon Park, Sun Young Rha, Lin Shen, Shukui Qin, Nong Xu, Seock-Ah Im, Gershon Locker, Phil Rowe, Xiaojin Shi, Darren Hodgson, Yu-Zhen Liu, Narikazu Boku

LANCET ONCOLOGY 18(12) 1637 - 1651 12 2017 Peer-reviewed
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Yoon-Koo Kang, Narikazu Boku, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, Kun-Huei Yeh, Takaki Yoshikawa, Sang Cheul Oh, Li-Yuan Bai, Takao Tamura, Keun-Wook Lee, Yasuo Hamamoto, Jong Gwang Kim, Keisho Chin, Do-Youn Oh, Keiko Minashi, Jae Yong Cho, Masahiro Tsuda, Li-Tzong Chen

LANCET 390(10111) 2461 - 2471 12 2017 Peer-reviewed

Presentations

7. Randomizedphase II/III study of FLvs. FLTAX in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G

Hara H, Nakajima TE, Yamaguchi K, Boku N, Hyodo I, Mizusawa J, Nishina T, Sakamoto T, Shitara K, Shinozaki K, Katayama H, Nakamura S

3 2019
6. Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G

Yamaguchi K, Nakajima TE, Boku N, Hyodo I, Mizusawa J, Hara H, Nishina T, Sakamoto T, Shitara K, Shinozaki K, Katayama H, Nakamura S

ASCO-GI 1 2019
5. CT image features of peritoneal metastasis and outcomes of the advanced gastric cancer patients receiving 2nd line chemotherapy

Kita S, Takashima A, Hirano H, Aoki M, Imazeki H, Ishikawa M, Shoji H, Honma Y, Iwasa S, Okita N, Kato K, Nagashima K, Boku N

ESMO-Asia 11 2018
4. Impact of adding ramucirumab to paclitaxel in patients with advanced gastric cancer according to the level of ascites

Kawai S, Masuishi T, Kadowaki S, Hirano H, Yamada T, Moriwaki T, Boku N, Muro K, Machida N

7 2018
3. Impact of ascites on the treatment of nivolumab for advanced gastric cancer patients

Higashiyama R, Kato K, Kano T, Oshiro Y, Miyamoto T, Hirano H, Shoji H, Iwasa S, Honma Y, Okita N, Takashima A, Boku N

7 2018